Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02758249Completed
Randomised trial of propofol injection (veterinary) and sevoflurane in breast cancer (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Immune cell (NK cell and CD8+ T cell) activity up to 24 hours. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02758249.